
<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en"> <![endif]-->
<!--[if IE 7]><html class="no-js lt-ie9 lt-ie8" lang="en"> <![endif]-->
<!--[if IE 8]><html class="no-js lt-ie9" lang="en"> <![endif]-->
<!--[if gt IE 8]><!--><html class="no-js" lang="en"><!--<![endif]-->
<head profile="http://gmpg.org/xfn/11">
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">

	<title>
  	Five Reasons Illumina Should Fight Roche&#039;s Insulting Low-Ball Bid | Xconomy	</title>

  <!-- chartbeat init -->

	<script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script>

    
	<link rel="shortcut icon" href="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/favicon.ico"/>

	<link rel="stylesheet" href="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/style.css" type="text/css" media="all" />

	<!--[if !IE]><!-->
	<style>
	.longNav {
	  position: fixed;
	  z-index: 9998;
	}
	.reveal {
	  z-index: 9995;
	}
	.xconomy {
	  padding-top: 86px;
	}
	.xperience .xconomy {
	    padding-top: 0;
	}
	</style>
	<!--<![endif]-->

	<link rel="alternate" type="application/rss+xml"
		title="Xconomy RSS Feed"
		href="http://feeds.feedburner.com/Xconomy_Full" />
	<meta name="google-site-verification" content="kB8sd1DYBBxgDN18IeVmM224YUBB03iZS3Z3kL6qXBw" />


<!-- This site is optimized with the Yoast WordPress SEO plugin v1.5.3.3 - https://yoast.com/wordpress/plugins/seo/ -->
<link rel="original-source" href="" />
<meta name="description" content="Illumina is like the Apple of the genomics business. Tools made by the San Diego company (NASDAQ: ]) are revered by genomics researchers around the world j"/>
<link rel="canonical" href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/" />
<link rel="next" href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/2/" />
<link rel="author" href="https://plus.google.com/u/0/117971461764998574099"/>
<link rel="publisher" href="https://plus.google.com/+Xconomy"/>
<meta property="og:locale" content="en_US" />
<meta property="og:type" content="article" />
<meta property="og:title" content="Five Reasons Illumina Should Fight Roche&#039;s Insulting Low-Ball Bid | Xconomy" />
<meta property="og:description" content="Illumina is like the Apple of the genomics business. Tools made by the San Diego company (NASDAQ: ]) are revered by genomics researchers around the world j" />
<meta property="og:url" content="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/" />
<meta property="og:site_name" content="Xconomy" />
<meta property="article:tag" content="BioBeat" />
<meta property="article:tag" content="Genomics" />
<meta property="article:tag" content="acquisitions" />
<meta property="article:tag" content="Life Sciences" />
<meta property="article:tag" content="Roche" />
<meta property="article:tag" content="Illumina" />
<meta property="article:tag" content="Jay Flatley" />
<meta property="article:tag" content="Severin Schwan" />
<meta property="article:tag" content="Daniel O&#039;Day" />
<meta property="article:tag" content="Diagnostics" />
<meta property="article:tag" content="cancer" />
<meta property="article:tag" content="Drugs" />
<meta property="article:tag" content="Genentech" />
<meta property="article:section" content="National" />
<meta property="article:section" content="National blog main" />
<meta property="article:section" content="National top stories" />
<meta property="article:section" content="Boston blog main" />
<meta property="article:section" content="Boston top stories" />
<meta property="article:section" content="Detroit blog main" />
<meta property="article:section" content="Detroit top stories" />
<meta property="article:section" content="New York blog main" />
<meta property="article:section" content="New York top stories" />
<meta property="article:section" content="San Diego blog main" />
<meta property="article:section" content="San Diego top stories" />
<meta property="article:section" content="San Francisco blog main" />
<meta property="article:section" content="San Francisco top stories" />
<meta property="article:section" content="Seattle blog main" />
<meta property="article:section" content="Seattle top stories" />
<meta property="article:published_time" content="2012-03-05T03:05:48+00:00" />
<meta property="article:modified_time" content="2012-03-02T21:52:28+00:00" />
<meta property="og:updated_time" content="2012-03-02T21:52:28+00:00" />
<meta property="og:image" content="http://www.xconomy.com/wordpress/wp-content/images/2011/12/BioBeatlogo.gif" />
<meta name="twitter:card" content="summary"/>
<meta name="twitter:site" content="@xconomy"/>
<meta name="twitter:domain" content="Xconomy"/>
<meta name="twitter:creator" content="@xconomy"/>
<!-- / Yoast WordPress SEO plugin. -->


            <script type="text/javascript">//<![CDATA[
            // Google Analytics for WordPress by Yoast v4.3.5 | http://yoast.com/wordpress/google-analytics/
            var _gaq = _gaq || [];
            _gaq.push(['_setAccount', 'UA-2143803-1']);
				            _gaq.push(['_setCustomVar',2,'post_type','post',3],['_setCustomVar',3,'author','luke-timmerman',3],['_setCustomVar',4,'year','2012',3],['_setCustomVar',5,'categories','national national-blog-main national-editors-picks bos',3],['_trackPageview']);
            (function () {
                var ga = document.createElement('script');
                ga.type = 'text/javascript';
                ga.async = true;
                ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';

                var s = document.getElementsByTagName('script')[0];
                s.parentNode.insertBefore(ga, s);
            })();
            //]]></script>
			<link rel="alternate" type="application/rss+xml" title="Xconomy &raquo; Five Reasons Illumina Should Fight Roche&#8217;s Insulting Low-Ball Bid Comments Feed" href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/feed/" />
<link rel='stylesheet' id='fancybox-css'  href='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/js/fancybox/jquery.fancybox-1.3.4.css?ver=1.3.4a' type='text/css' media='screen' />
<link rel='stylesheet' id='ps-photoswipe-style-css'  href='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/css/photoswipe.min.css?ver=1.7.4' type='text/css' media='screen' />
<link rel='stylesheet' id='wp-email-css'  href='http://www.xconomy.com/wordpress/wp-content/plugins/wp-email/email-css.css?ver=2.60' type='text/css' media='all' />
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-includes/js/jquery/jquery.js?ver=1.10.2'></script>
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.2.1'></script>
<link rel='shortlink' href='http://www.xconomy.com/?p=181399' />

<!-- Portfolio Slideshow-->
<noscript><link rel="stylesheet" type="text/css" href="http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/css/portfolio-slideshow-noscript.css?ver=1.7.4" /></noscript><style type="text/css">.centered a.next.browse.right {} .scrollable {height:140px;} a.prev.browse.left {top:75px} a.next.browse.right {top:-80px} .slideshow-wrapper .pscarousel img {margin-right:10px !important; margin-bottom:10px !important;} }</style><script type="text/javascript">/* <![CDATA[ */var psTimeout = new Array(); psAudio = new Array(); var psAutoplay = new Array(); var psDelay = new Array(); var psFluid = new Array(); var psTrans = new Array(); var psRandom = new Array(); var psCarouselSize = new Array(); var touchWipe = new Array(); var psPagerStyle = new Array(); psCarousel = new Array(); var psSpeed = new Array(); var psLoop = new Array(); var psClickOpens = new Array(); /* ]]> */</script>
<!--//Portfolio Slideshow-->

 <script type='text/javascript'>
	var googletag = googletag || {};
	googletag.cmd = googletag.cmd || [];
</script>


    
<script type="text/javascript">
var xcKeywords = ",national,life-sciences, ";
</script>


<script type="text/javascript">var proto = "http:"; if (document.location.protocol == "https:") { proto = "https:" }var z=document.createElement("script");z.type="text/javascript";z.async=true;z.src= proto + "//static.xconomy.com/ados.js";var s = document.getElementsByTagName("script")[0];s.parentNode.insertBefore(z, s);</script>
<script type="text/javascript">
var ados = ados || {};
ados.run = ados.run || [];
<!-- load placement for account: Xconomy, site: Xconomy, size: 125x125 - Square Button, zone: underwriter - SIDEBAR-->
        ados.run.push(function() {
        ados_setKeywords(',national,life-sciences, ');
        ados_add_placement(946,14419,"z0",16).setZone(12822);
        ados_setDomain('engine.xconomy.com');
        ados_load();
    });
    ados.run.push(function() {
        ados_setKeywords(',national,life-sciences, ');
                    ados_add_placement(946,14419,"z1",16).setZone(1563);
                    ados_add_placement(946,14419,"z2",16).setZone(1563);
                    ados_add_placement(946,14419,"z3",16).setZone(1563);
                    ados_add_placement(946,14419,"z4",16).setZone(1563);
                    ados_add_placement(946,14419,"z5",16).setZone(1563);
                    ados_add_placement(946,14419,"z6",16).setZone(1563);
                    ados_add_placement(946,14419,"z7",16).setZone(1563);
                    ados_add_placement(946,14419,"z8",16).setZone(1563);
                    ados_add_placement(946,14419,"z9",16).setZone(1563);
                    ados_add_placement(946,14419,"z10",16).setZone(1563);
                    ados_add_placement(946,14419,"z11",16).setZone(1563);
                    ados_add_placement(946,14419,"z12",16).setZone(1563);
                    ados_add_placement(946,14419,"z13",16).setZone(1563);
                    ados_add_placement(946,14419,"z14",16).setZone(1563);
                    ados_add_placement(946,14419,"z15",16).setZone(1563);
                    ados_add_placement(946,14419,"z16",16).setZone(1563);
                    ados_add_placement(946,14419,"z17",16).setZone(1563);
            ados_setDomain('engine.xconomy.com');
    ados_load();
    });
</script>

<script type="text/javascript" src="http://static.xconomy.com/ados.js"></script>
<script type="text/javascript">
ados.isAsync = false;
ados_setKeywords(',national,life-sciences, ');

<!-- Leaderboard -->
<!-- load placement for account: Xconomy, site: Xconomy, size: 728x90 - Leaderboard, zone: banner - LEADERBOARD-->
ados_add_placement(946, 14419, "az_leaderboard_1", 4).setZone(1558);
<!-- load placement for account: Xconomy, site: Xconomy, size: 121x90 - 121x90, zone: underwriter - VERTICALS-->
ados_add_placement(946, 14419, "az_verticals_1", 65).setZone(1565);
<!-- load placement for account: Xconomy, site: Xconomy, size: 121x90 - 121x90, zone: underwriter - VERTICALS-->
ados_add_placement(946, 14419, "az_verticals_2", 65).setZone(1565);

<!-- Page Ads -->
    <!-- load placement for account: Xconomy, site: Xconomy, size: 300x250 - Medium Rectangle, zone: banner - STORY RECTANGLE-->
    ados_add_placement(946, 14419, "az_single_1", 5).setZone(1562);
<!-- load placement for account: Xconomy, site: Xconomy, size: 300x250 - Medium Rectangle, zone: banner - SIDEBAR RECTANGLE 1-->
ados_add_placement(946, 14419, "az_sidebar_1", 5).setZone(1560);
<!-- load placement for account: Xconomy, site: Xconomy, size: 300x250 - Medium Rectangle, zone: banner - SIDEBAR RECTANGLE 2-->
ados_add_placement(946, 14419, "az_sidebar_2", 5).setZone(1561);

ados_setDomain('engine.xconomy.com');
ados_load();
</script>

</head>
<body
	class="national story">

  <div class="longNav">
    <ul class="primary clearFix">
      <span class="cityNameGhost"></span>
      <li class="sub" style="float:right;">
        <div class="half subscribe long">
          <a href="/rss-feeds">Subscribe for Free (RSS + E-mail)</a>
        </div>
        <div class="half subscribe short">
          <a href="/rss-feeds">RSS + E-mail</a>
        </div>
        <div class="half featured long">
            <p class="mbn">
                                        <p><a href="/seattle/2013/10/16/seattle-serial-entrepreneurs-advice-wish-theyd-heard-earlier-5/" class="featured">Top Entrepreneurs' Advice  →</a></p>                            <span>&#9662;</span>

            </p>
            <ul class="reveal clearFix" style="width:100%;">
                                                <li>
                        <p><a href="/detroit/innovation-champions-join/" class="featured">Support Xconomy Detroit →</a></p>                    </li>
                                    <li>
                        <p><a href="/seattle/2013/10/16/seattle-serial-entrepreneurs-advice-wish-theyd-heard-earlier-5/" class="featured">Top Entrepreneurs' Advice  →</a></p>                    </li>
                                    <li>
                        <p><a href="/boston/2012/10/03/top-angel-investors-of-new-england-an-innovation-slideshow/" class="featured">Boston Angel Investors →</a></p>
                    </li>
                                    <li>
                        <p><a href="/incubators2012/" class="featured">Incubator Guide →</a></p>
                    </li>
                                    <li>
                        <a class="featured" href="/san-francisco/2014/05/14/sacramento-innovation/">The Sacramento-Davis Corridor →</a>
                    </li>
                            </ul>
        </div>
        <div class="half featured short">
            <p class="mbn">
            <a>Featured <span>&#9662;</span></a>
            </p>
            <ul class="reveal clearFix">
                                                                    <li>
                        <p><a href="/detroit/innovation-champions-join/" class="featured">Support Xconomy Detroit →</a></p>                    </li>
                                                    <li>
                        <p><a href="/incubators2012/" class="featured">Incubator Guide →</a></p>
                    </li>
                                                    <li>
                        <p><a href="/seattle/2013/10/16/seattle-serial-entrepreneurs-advice-wish-theyd-heard-earlier-5/" class="featured">Top Entrepreneurs' Advice  →</a></p>                    </li>
                                                    <li>
                        <p><a href="/boston/2012/10/03/top-angel-investors-of-new-england-an-innovation-slideshow/" class="featured">Boston Angel Investors →</a></p>
                    </li>
                                                    <li>
                        <a class="featured" href="/san-francisco/2014/05/14/sacramento-innovation/">The Sacramento-Davis Corridor →</a>
                    </li>
                            </ul>

        </div>
      </li>



      <li class="logo mn">
        <h1 id="logo"><a href="/" class="primary">Xconomy National</a></h1>
      </li><li class="mn xps">
          <a class="nlo primary" href="/xperience">Xperience<br />Tech + Life<span class="drop">&#9662;</span></a>
          <ul class="reveal clearFix pal">
                <li>
                  <ul class="storyList">
                                                                        <li class="clearFix mbl">
                            <div class="thumb">
                                <a href="http://www.xconomy.com/new-york/2014/06/30/ce-week-takeaway-device-makers-want-to-connect-all-the-things/" title="CE Week Takeaway: Device Makers Want to “Connect All the Things”">
                                <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/ceweeksharp3-140x92.jpg" class="lazy" alt="CE Week Takeaway: Device Makers Want to “Connect All the Things”" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/ceweeksharp3-140x92.jpg" alt="CE Week Takeaway: Device Makers Want to “Connect All the Things”" /></noscript>
                                </a>
                            </div>
                            <h6>
                                <a href="http://www.xconomy.com/new-york/2014/06/30/ce-week-takeaway-device-makers-want-to-connect-all-the-things/" title="CE Week Takeaway: Device Makers Want to “Connect All the Things”">
                                    CE Week Takeaway: Device Makers Want to “Connect All the Things”                                </a>
                            </h6>
                        </li>
                                                <li class="clearFix mbl">
                            <div class="thumb">
                                <a href="http://www.xconomy.com/national/2014/06/27/wanted-startups-to-fix-e-mail-conferencing-audio-av-calendars/" title="Five Annoying Tech Problems for the Next Hot Startup to Solve">
                                <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/vox59-main-140x93.jpg" class="lazy" alt="Five Annoying Tech Problems for the Next Hot Startup to Solve" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/vox59-main-140x93.jpg" alt="Five Annoying Tech Problems for the Next Hot Startup to Solve" /></noscript>
                                </a>
                            </div>
                            <h6>
                                <a href="http://www.xconomy.com/national/2014/06/27/wanted-startups-to-fix-e-mail-conferencing-audio-av-calendars/" title="Five Annoying Tech Problems for the Next Hot Startup to Solve">
                                    Five Annoying Tech Problems for the Next Hot Startup to Solve                                </a>
                            </h6>
                        </li>
                                                <li class="clearFix mbl">
                            <div class="thumb">
                                <a href="http://www.xconomy.com/national/2014/06/25/dont-want-google-in-your-house-some-home-tech-startups-to-watch/" title="Don’t Want Google in Your House? Some Home-Tech Startups to Watch">
                                <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/Googleplex-Sign-140x93.png" class="lazy" alt="Don’t Want Google in Your House? Some Home-Tech Startups to Watch" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/Googleplex-Sign-140x93.png" alt="Don’t Want Google in Your House? Some Home-Tech Startups to Watch" /></noscript>
                                </a>
                            </div>
                            <h6>
                                <a href="http://www.xconomy.com/national/2014/06/25/dont-want-google-in-your-house-some-home-tech-startups-to-watch/" title="Don’t Want Google in Your House? Some Home-Tech Startups to Watch">
                                    Don’t Want Google in Your House? Some Home-Tech Startups to Watch                                </a>
                            </h6>
                        </li>
                                                <li class="clearFix mbl">
                            <div class="thumb">
                                <a href="http://www.xconomy.com/new-york/2014/06/23/connected-devices-and-the-internet-of-things-knocking-at-your-door/" title="Connected Devices and the Internet of Things Knocking at Your Door">
                                <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/doorbot-140x93.jpg" class="lazy" alt="Connected Devices and the Internet of Things Knocking at Your Door" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/doorbot-140x93.jpg" alt="Connected Devices and the Internet of Things Knocking at Your Door" /></noscript>
                                </a>
                            </div>
                            <h6>
                                <a href="http://www.xconomy.com/new-york/2014/06/23/connected-devices-and-the-internet-of-things-knocking-at-your-door/" title="Connected Devices and the Internet of Things Knocking at Your Door">
                                    Connected Devices and the Internet of Things Knocking at Your Door                                </a>
                            </h6>
                        </li>
                                                <li class="clearFix mbl">
                            <div class="thumb">
                                <a href="http://www.xconomy.com/national/2014/06/20/pogoplug-one-service-to-back-up-all-your-devices/" title="Pogoplug: One Service to Back Up All Your Devices">
                                <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/vox58-main-140x93.jpg" class="lazy" alt="Pogoplug: One Service to Back Up All Your Devices" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/vox58-main-140x93.jpg" alt="Pogoplug: One Service to Back Up All Your Devices" /></noscript>
                                </a>
                            </div>
                            <h6>
                                <a href="http://www.xconomy.com/national/2014/06/20/pogoplug-one-service-to-back-up-all-your-devices/" title="Pogoplug: One Service to Back Up All Your Devices">
                                    Pogoplug: One Service to Back Up All Your Devices                                </a>
                            </h6>
                        </li>
                                          </ul>
                  <a href="/xperience" class="moreNav mbn">View More in Xperience ›</a>

                </li>
            </ul>
      </li><li class="mn cities">
        <a class="city nlo primary" href="/cities">Our<br /> Regions<span class="drop">&#9662;</span></a>
        <ul class="reveal clearFix pal">
          <div class="yui3-g">
          <div class="yui3-u-1-3">
            <div class="col1 border mrl">
            <li>
              <a class="cityName" href="/boston">Boston<span>›</span></a>
              <ul class="storyList">
                                    
                    <li>
                                  <div class="thumb">
                                     <a href="http://www.xconomy.com/boston/2014/07/01/ex-genentecher-kelsey-grabs-reins-at-modernas-onkaido-therapeutics/" title="Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2013/11/moderna1-140x93.png" class="lazy" alt="Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2013/11/moderna1-140x93.png" alt="Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics" /></noscript>
                                    </a>
                                    </div>
                                    <h6>
                                        <a href="http://www.xconomy.com/boston/2014/07/01/ex-genentecher-kelsey-grabs-reins-at-modernas-onkaido-therapeutics/" title="Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics">
                                            Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics                                        </a>
                                    </h6>
                                                                    </li>
              </ul>
              <a href="/boston" class="moreNav">View More in Boston ›</a>

            </li>
            <li>
              <a class="cityName" href="/boulder-denver">Boulder/Denver<span>›</span></a>
              <ul class="storyList">
                                    
                    <li>
                                  <div class="thumb">
                                     <a href="http://www.xconomy.com/boulder-denver/2014/07/01/gnip-twitter-datalogix-and-vc-rounds-top-colorado-stories-for-2q/" title="Gnip, Twitter, Datalogix, and VC Rounds Top Colorado Stories for 2Q">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2013/10/CUbioBig-140x93.png" class="lazy" alt="Gnip, Twitter, Datalogix, and VC Rounds Top Colorado Stories for 2Q" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2013/10/CUbioBig-140x93.png" alt="Gnip, Twitter, Datalogix, and VC Rounds Top Colorado Stories for 2Q" /></noscript>
                                    </a>
                                    </div>
                                    <h6>
                                        <a href="http://www.xconomy.com/boulder-denver/2014/07/01/gnip-twitter-datalogix-and-vc-rounds-top-colorado-stories-for-2q/" title="Gnip, Twitter, Datalogix, and VC Rounds Top Colorado Stories for 2Q">
                                            Gnip, Twitter, Datalogix, and VC Rounds Top Colorado Stories for 2Q                                        </a>
                                    </h6>
                                                                  </li>

              </ul>
              <a href="/boulder-denver" class="moreNav">View More in Boulder/Denver ›</a>

            </li>
            <li>
              <a class="cityName" href="/detroit">Detroit<span>›</span></a>
              <ul class="storyList">
                                                  <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/detroit/2014/07/01/roundup-upwardly-global-boostup-jacapps-quicken-loans-sakti3/" title="Roundup: Upwardly Global, BoostUp, Jacapps, Quicken Loans, Sakti3">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2011/11/StockRoundup1-140x93.jpg" class="lazy" alt="Roundup: Upwardly Global, BoostUp, Jacapps, Quicken Loans, Sakti3" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2011/11/StockRoundup1-140x93.jpg" alt="Roundup: Upwardly Global, BoostUp, Jacapps, Quicken Loans, Sakti3" /></noscript>
                                    </a>
                                </div>
                            <h6>
                                <a href="http://www.xconomy.com/detroit/2014/07/01/roundup-upwardly-global-boostup-jacapps-quicken-loans-sakti3/" title="Roundup: Upwardly Global, BoostUp, Jacapps, Quicken Loans, Sakti3">
                                    Roundup: Upwardly Global, BoostUp, Jacapps, Quicken Loans, Sakti3                                </a>
                            </h6>

                            </li>
                          
              </ul>
              <a href="/detroit" class="moreNav">View More in Detroit ›</a>

            </li>
              </div>
            </div>

          <div class="yui3-u-1-3">
              <div class="col1 border">
                  <li>
                    <a class="cityName" href="/new-york">New York<span>›</span></a>
                    <ul class="storyList">
                                                                          <li>
                                          <div class="thumb">
                                         <a href="http://www.xconomy.com/new-york/2014/07/01/twitter-buys-tapcommerce-increases-its-strength-in-mobile-adtech/" title="Twitter Buys TapCommerce, Increases Its Strength in Mobile Adtech">
                                            <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2013/11/tapcommerce-140x93.jpg" class="lazy" alt="Twitter Buys TapCommerce, Increases Its Strength in Mobile Adtech" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2013/11/tapcommerce-140x93.jpg" alt="Twitter Buys TapCommerce, Increases Its Strength in Mobile Adtech" /></noscript>
                                        </a>
                                        </div>
                                        <h6>
                                            <a href="http://www.xconomy.com/new-york/2014/07/01/twitter-buys-tapcommerce-increases-its-strength-in-mobile-adtech/" title="Twitter Buys TapCommerce, Increases Its Strength in Mobile Adtech">
                                                Twitter Buys TapCommerce, Increases Its Strength in Mobile Adtech                                            </a>
                                        </h6>
                                        </li>
                                        
                    </ul>
                    <a href="/new-york" class="moreNav">View More in New York ›</a>

                  </li>
             <li>
              <a class="cityName" href="/san-diego">San Diego<span>›</span></a>
              <ul class="storyList">
                                                      <li>
                  <div class="thumb">
                         <a href="http://www.xconomy.com/wisconsin/2014/07/01/steve-wozniak-on-galaxy-gear-google-glass-future-of-wearables/" title="Steve Wozniak on Galaxy Gear, Google Glass, &#038; Future of Wearables">
                            <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/SteveWozniak-FlyingCar-2014-140x93.jpg" class="lazy" alt="Steve Wozniak on Galaxy Gear, Google Glass, &#038; Future of Wearables" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/SteveWozniak-FlyingCar-2014-140x93.jpg" alt="Steve Wozniak on Galaxy Gear, Google Glass, &#038; Future of Wearables" /></noscript>
                        </a>
                    </div>
                    <h6>
                        <a href="http://www.xconomy.com/wisconsin/2014/07/01/steve-wozniak-on-galaxy-gear-google-glass-future-of-wearables/" title="Steve Wozniak on Galaxy Gear, Google Glass, &#038; Future of Wearables">
                            Steve Wozniak on Galaxy Gear, Google Glass, &#038; Future of Wearables                        </a>
                    </h6>
                </li>
                                        </ul>
              <a href="/san-diego" class="moreNav">View More in San Diego ›</a>

            </li>
            <li>
              <a class="cityName" href="/san-francisco">San Francisco<span>›</span></a>
                 <ul class="storyList">
                                                                  <li>
                                  <div class="thumb">
                                     <a href="http://www.xconomy.com/wisconsin/2014/07/02/chamber-hopes-pitches-could-boost-silicon-valley-madison-vc-deals/" title="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/Handshake-140x93.jpg" class="lazy" alt="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/Handshake-140x93.jpg" alt="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals" /></noscript>
                                    </a>
                                    </div>
                                  <h6>
                                        <a href="http://www.xconomy.com/wisconsin/2014/07/02/chamber-hopes-pitches-could-boost-silicon-valley-madison-vc-deals/" title="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals">
                                            Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals                                        </a>
                                    </h6>
                                </li>
                                                        </ul>
                  <a href="/san-francisco" class="moreNav">View More in San Francisco ›</a>

            </li>
                </div>
              </div>

            <div class="yui3-u-1-3">
                <div class="border mll">
            <li>
            <a class="cityName" href="/seattle">Seattle<span>›</span></a>
               <ul class="storyList">
                                                       <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/boulder-denver/2014/06/30/new-partnership-will-ease-startup-accelerator-application-process/" title="New Partnership Will Ease Startup Accelerator Application Process">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/StartupNextBW-140x93.jpg" class="lazy" alt="New Partnership Will Ease Startup Accelerator Application Process" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/StartupNextBW-140x93.jpg" alt="New Partnership Will Ease Startup Accelerator Application Process" /></noscript>
                                    </a>
                                </div>
                                <h6>
                                    <a href="http://www.xconomy.com/boulder-denver/2014/06/30/new-partnership-will-ease-startup-accelerator-application-process/" title="New Partnership Will Ease Startup Accelerator Application Process">
                                        New Partnership Will Ease Startup Accelerator Application Process                                    </a>
                                </h6>
                    </li>
                                                          </ul>
                <a href="/seattle" class="moreNav">View More in Seattle ›</a>

            </li>
            <li>
            <a class="cityName" href="/texas">Texas<span>›</span></a>
               <ul class="storyList">
                                                                      <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/texas/2014/06/30/austins-bigcommerce-taps-steve-cases-fund-to-take-on-amazon/" title="Austin’s Bigcommerce Taps Steve Case’s Fund to Take On Amazon">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/bclogo-140x89.png" class="lazy" alt="Austin’s Bigcommerce Taps Steve Case’s Fund to Take On Amazon" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/bclogo-140x89.png" alt="Austin’s Bigcommerce Taps Steve Case’s Fund to Take On Amazon" /></noscript>
                                    </a>
                                </div>
                                <h6>
                                    <a href="http://www.xconomy.com/texas/2014/06/30/austins-bigcommerce-taps-steve-cases-fund-to-take-on-amazon/" title="Austin’s Bigcommerce Taps Steve Case’s Fund to Take On Amazon">
                                        Austin’s Bigcommerce Taps Steve Case’s Fund to Take On Amazon                                    </a>
                                </h6>
                    </li>
                                                          </ul>
                <a href="/texas" class="moreNav">View More in Texas ›</a>

            </li>
<li>
            <a class="cityName" href="/wisconsin">Wisconsin<span>›</span></a>
               <ul class="storyList">
                                                                      <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/wisconsin/2014/07/02/chamber-hopes-pitches-could-boost-silicon-valley-madison-vc-deals/" title="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/Handshake-140x93.jpg" class="lazy" alt="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/Handshake-140x93.jpg" alt="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals" /></noscript>
                                    </a>
                                </div>
                                <h6>
                                    <a href="http://www.xconomy.com/wisconsin/2014/07/02/chamber-hopes-pitches-could-boost-silicon-valley-madison-vc-deals/" title="Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals">
                                        Chamber Hopes Pitches Could Boost Silicon Valley-Madison VC Deals                                    </a>
                                </h6>
                    </li>
                                                          </ul>
                <a href="/wisconsin" class="moreNav">View More in Wisconsin ›</a>

            </li>
          </div>
          </div>
        </ul>
      </li><li class="mn">
        <a href="/channels" class="channel nlo primary">Tech<br /> Channels <span class="drop">&#9662;</span></a>
        <ul class="reveal clearFix pal">
          <div class="yui3-g">
          <div class="col1 yui3-u-1-2">
            <div class="border mrl">
                            <li>
              <a class="cityName" href="/cleantech">Cleantech<span>›</span></a>
              <ul class="storyList">
                                                                <li>
                                  <div class="thumb">
                                     <a href="http://www.xconomy.com/texas/2014/06/13/houstons-chai-one-sees-a-role-for-the-internet-of-things-in-industry/" title="Houston’s ChaiOne Sees a Role for the Internet of Things in Industry">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/chaione-140x75.png" class="lazy" alt="Houston’s ChaiOne Sees a Role for the Internet of Things in Industry" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/06/chaione-140x75.png" alt="Houston’s ChaiOne Sees a Role for the Internet of Things in Industry" /></noscript>
                                    </a>
                                    </div>
                                    <h6>
                                        <a href="http://www.xconomy.com/texas/2014/06/13/houstons-chai-one-sees-a-role-for-the-internet-of-things-in-industry/" title="Houston’s ChaiOne Sees a Role for the Internet of Things in Industry">
                                            Houston’s ChaiOne Sees a Role for the Internet of Things in Industry                                        </a>
                                    </h6>
                                </li>
                                            </ul>
              <a href="/cleantech" class="moreNav">View More in Cleantech ›</a>

            </li>
            <li>
              <a class="cityName" href="/healthtech">Healthtech<span>›</span></a>
              <ul class="storyList">

                                                            <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/wisconsin/2014/06/02/wisconsin-roundup-epic-crowdfunding-milwaukee-water-biz-park/" title="Wisconsin Roundup: Epic, Crowdfunding, Milwaukee Water Biz Park">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/WisconsinStock-140x93.jpg" class="lazy" alt="Wisconsin Roundup: Epic, Crowdfunding, Milwaukee Water Biz Park" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/04/WisconsinStock-140x93.jpg" alt="Wisconsin Roundup: Epic, Crowdfunding, Milwaukee Water Biz Park" /></noscript>
                                    </a>
                                </div>
                            <h6>
                                <a href="http://www.xconomy.com/wisconsin/2014/06/02/wisconsin-roundup-epic-crowdfunding-milwaukee-water-biz-park/" title="Wisconsin Roundup: Epic, Crowdfunding, Milwaukee Water Biz Park">
                                    Wisconsin Roundup: Epic, Crowdfunding, Milwaukee Water Biz Park                                </a>
                            </h6>

                            </li>
                          
              </ul>
              <a href="/healthtech" class="moreNav">View More in Healthtech ›</a>

            </li>
            <li>
              <a class="cityName" href="/life-sciences">Life Sciences<span>›</span></a>
              <ul class="storyList">
                                                              <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/seattle/2014/06/30/saying-nothing-with-style-the-2014-biopharma-edition-of-bs-bingo/" title="Saying Nothing With Style: The 2014 BioPharma Edition of BS Bingo">
                                        
                                    </a>
                                </div>
                                <h6>
                                    <a href="http://www.xconomy.com/seattle/2014/06/30/saying-nothing-with-style-the-2014-biopharma-edition-of-bs-bingo/" title="Saying Nothing With Style: The 2014 BioPharma Edition of BS Bingo">
                                        Saying Nothing With Style: The 2014 BioPharma Edition of BS Bingo                                    </a>
                                </h6>
                            </li>
                                                    </ul>
              <a href="/life-sciences" class="moreNav">View More in Life Sciences ›</a>

            </li>
            </div>
          </div>
          <div class="col2 yui3-u-1-2">
            <li>
            <a class="cityName" href="/mobile">Mobile<span>›</span></a>
               <ul class="storyList">
                                                                              <li>
                                <div class="thumb">
                                     <a href="http://www.xconomy.com/san-diego/2014/06/02/an-opera-festival-holds-the-seeds-for-a-tech-revolution-in-tijuana/" title="An Opera Festival Holds the Seeds for a Tech Revolution in Tijuana">
                                        <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/05/Tijuana-Opera-Street-Festival-2012-Sam-Quinones-140x93.jpg" class="lazy" alt="An Opera Festival Holds the Seeds for a Tech Revolution in Tijuana" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/05/Tijuana-Opera-Street-Festival-2012-Sam-Quinones-140x93.jpg" alt="An Opera Festival Holds the Seeds for a Tech Revolution in Tijuana" /></noscript>
                                    </a>
                                </div>
                                <h6>
                                    <a href="http://www.xconomy.com/san-diego/2014/06/02/an-opera-festival-holds-the-seeds-for-a-tech-revolution-in-tijuana/" title="An Opera Festival Holds the Seeds for a Tech Revolution in Tijuana">
                                        An Opera Festival Holds the Seeds for a Tech Revolution in Tijuana                                    </a>
                                </h6>
                    </li>
                                                          </ul>
                <a href="/mobile"  class="moreNav">View More in Mobile ›</a>

            </li>
            <li>
              <a class="cityName" href="/startups">Startups<span>›</span></a>
              <ul class="storyList">
                                                                        <li>
                  <div class="thumb">
                         <a href="http://www.xconomy.com/boston/2014/06/02/dean-kamen-coptering-in-to-inspire-crowd-at-boston-2034-on-june-10/" title="Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10">
                            <img data-src="http://www.xconomy.com/wordpress/wp-content/images/2014/03/boston2034wp2-140x93.gif" class="lazy" alt="Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10" width="80px"/><noscript><img class="lazy" src="http://www.xconomy.com/wordpress/wp-content/images/2014/03/boston2034wp2-140x93.gif" alt="Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10" /></noscript>
                        </a>
                    </div>
                    <h6>
                        <a href="http://www.xconomy.com/boston/2014/06/02/dean-kamen-coptering-in-to-inspire-crowd-at-boston-2034-on-june-10/" title="Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10">
                            Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10                        </a>
                    </h6>
                </li>
                                        </ul>
              <a href="/startups" class="moreNav">View More in Startups ›</a>

            </li>
          </div>
          </div>
        </ul>
      </li><li class="mn xconomists">
        <a href="http://www.xconomy.com/about/#The%20Xconomists"  class="xcon nlo primary">Meet the<br />Xconomists <span class="drop">&#9662;</span></a>
        <ul class="reveal clearFix xcs pal">
          <div class="yui3-g">
          <div class="col1 yui3-u-1-2">
            <div class="border mrl">

          
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/aory-502.jpg" alt="Andy Ory" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/aory/"
                             title = "Posts by
                                Andy Ory">
                            Andy Ory                        </a>
                    </h1>
                    <p>
                        Founder and CEO, Acme Packet                    </p>
                    </li>

                
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/bdalton-365.png" alt="Barbara Dalton" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/bdalton/"
                             title = "Posts by
                                Barbara Dalton">
                            Barbara Dalton                        </a>
                    </h1>
                    <p>
                        VP of Venture Capital, Pfizer Inc.                    </p>
                    </li>

                
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/amellor-846.jpg" alt="Art Mellor" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/amellor/"
                             title = "Posts by
                                Art Mellor">
                            Art Mellor                        </a>
                    </h1>
                    <p>
                        CEO of Zero Locus                    </p>
                    </li>

                
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/aborisy.jpg" alt="Alexis Borisy" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/aborisy/"
                             title = "Posts by
                                Alexis Borisy">
                            Alexis Borisy                        </a>
                    </h1>
                    <p>
                        Partner, Third Rock Ventures                    </p>
                    </li>

                                    <li style="margin-bottom: 0;">
              <a href="http://www.xconomy.com/about/#The%20Xconomists" class="moreNav buttons" style="margin-bottom:0;">Meet All the Xconomists ›</a>
              </li>
              </div>
            </div>
            <div class="col2 yui3-u-1-2">
            
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/aswift.jpg" alt="Anne Swift" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/aswift/"
                             title = "Posts by
                                Anne Swift">
                            Anne Swift                        </a>
                    </h1>
                    <p>
                        Founder, Young Inventors                    </p>
                    </li>

                    
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/dbaltimore-526.jpg" alt="David Baltimore" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/dbaltimore/"
                             title = "Posts by
                                David Baltimore">
                            David Baltimore                        </a>
                    </h1>
                    <p>
                        Nobel Laureate, Professor of Biology, Caltech                    </p>
                    </li>

                    
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/blorang-738.jpg" alt="Bart Lorang" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/blorang/"
                             title = "Posts by
                                Bart Lorang">
                            Bart Lorang                        </a>
                    </h1>
                    <p>
                        CEO, FullContact                    </p>
                    </li>

                    
                    <li class="entry clearFix">
                    <div class="avatar">
                        <div class="entry_author_image"><img src="http://www.xconomy.com/wordpress/wp-content/authors/acalifano-362.png" alt="Andrea Califano" /></div>
                    </div>
                    <h1>
                        <a href="http://www.xconomy.com/author/acalifano/"
                             title = "Posts by
                                Andrea Califano">
                            Andrea Califano                        </a>
                    </h1>
                    <p>
                        Professor of Systems Biology, Columbia University                    </p>
                    </li>

                              </div>

          </div>
            </ul>
      </li><li class="evnts mn">
        <a href="/events"  class="event nlo primary">Our<br />Events <span class="drop">&#9662;</span></a>
        <ul class="reveal evnts pal">
          <div>
                                  
          
          <li class="mbs">
            <a href="/events" class="moreNav buttons" style="margin-bottom:0;">View All Xconomy Events ›</a>
            <a href="/boston/local-events/" class="moreNav buttons" style="margin-bottom:0;">Boston Events ›</a>

          </li>
          <li class="mbs">
              <a href="/boulder-denver/local-events/" class="moreNav buttons mvn">Boulder/Denver Events ›</a>
              <a href="/detroit/local-events/" class="moreNav buttons mvn">Detroit Events ›</a>
          </li>
          <li class="mbs">
            <a href="/new-york/local-events/" class="moreNav buttons mvn">New York Events ›</a>
              <a href="/san-diego/local-events/" class="moreNav buttons mvn">San Diego Events ›</a>
        </li>
        <li class="mbs">
          <a href="/san-francisco/local-events/" class="moreNav buttons mvn">San Francisco Events ›</a>
          <a href="/seattle/local-events/" class="moreNav buttons mvn">Seattle Events ›</a>
        </li>
        <li class="mbn">
          <a href="/texas/local-events/" class="moreNav buttons mvn">Texas Events ›</a>
          <a href="/wisconsin/local-events/" class="moreNav buttons mvn">Wisconsin Events ›</a>
        </li>

                    </div>
        </ul>
      </li><li class="search mn">
        <form method="get" class="searchFormNational" action="http://www.xconomy.com/">
          <input id="searchBox" type="text" value="" name="s" placeholder="Search Xconomy" size="28" />
          <input type="submit" id="searchButton" value="" />
        </form>
      </li>
    </ul>
  </div>
<div class="xconomy">

	<div class="centerAlign ads adleader">
	<table class="advertisements">
		<tr>
			<td class="banner_ad">
				<img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/advertisement.gif" alt=""/>
			</td>

			<td class="banner_ad vtop">
				<!--/* Adzerk ad */-->
				<div id="az_leaderboard_1" style="height:90px; width: 728px; overflow:hidden;">
				<script type="text/javascript">
					ados_loadDiv("az_leaderboard_1");
				</script>
				</div>
			</td>
			<!-- channel ads -->
	  		<td class="banner_ad vtop">
	  			<!--/* Adzerk ad */-->
				<div id="az_verticals_1"></div>
			</td>
			<td class="banner_ad vtop">
	  			<!--/* Adzerk ad */-->
				<div id="az_verticals_2"></div>
			</td>
		</tr>
	</table>
	</div>
	<!-- done banner ad -->
		<div class="lovely pages">
        		<!-- Sub Nav -->
  					
		  
			
<!-- END HEADER (footer closes div)--><div id="az_inter_1">
	<script type="text/javascript">
		ados_loadDiv("az_inter_1");
	</script>
</div>
<div class="yui3-g">
    <div class="yui3-u-2-3">
        
<div class="wrapper clearFix">

		<!-- BEGIN CONTENT -->		
		<div class="stories">
		<div class="entry" id="single">
			
			  				<h1>
            Five Reasons Illumina Should Fight Roche&#8217;s Insulting Low-Ball Bid  				</h1>
						<h5>
				<a href="http://www.xconomy.com/author/ltimmerman/" title="Posts by Luke Timmerman" rel="author">Luke Timmerman</a><span class="normalize"><a href="http://www.xconomy.com/archives/?xyear=2012&amp;month=3&amp;xday=5">3/5/12</a></span><nobr><a href="https://twitter.com/xconomy"class="twitterFollow btn btn-mini" data-show-count="false" data-width="170px" target="_blank"><i></i>Follow @xconomy</a></nobr>			</h5>
      						
					      				<div class="story_sidebar">
											<div class="container">
						  						  						  <a href="http://www.xconomy.com/national/2011/12/12/the-hepatitis-c-market-biotechs-version-of-the-daytona-500/attachment/biobeatlogo/">
  						<img width="200" height="132" src="http://www.xconomy.com/wordpress/wp-content/images/2011/12/BioBeatlogo-220x146.gif" class="attachment-200x9999 wp-post-image" alt="BioBeatlogo" />	
  						</a>				
						</div>
					
					<div class="share_links">
					<h4>Share and Comment</h4>
					<a class="reprints commentCTA" id="orderReprint" href="#disqus_thread">
						<span class="dsq-postid" rel="181399 http://www.xconomy.com/?p=181399">11 Comments</span>					</a>
					<a class="reprints" id="orderReprint" href="/reprints">
						Order a Reprint
					</a>
					<a href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/email/"
						 title="E-mail"  id="emailArticle" rel="nofollow" target="_blank" class="reprints">
					E-mail this Story
					</a>
					<ul class="sharing social-buttons">
						<li class="twitters">
						<!-- Twitter link -->
							<a href="https://twitter.com/share"
								class="socialite twitter twitter-share shareWidget"
								data-url="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/"
								data-counturl="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/"
								data-related="bbuderi:Xconomy Founder"
								data-via="xconomy"
								data-count="vertical"><span class="vhidden">Share on Twitter</span></a>
						</li>
						<li class="faceBook">
							<!-- Facebook link -->
							<a class="socialite facebook facebook-like shareWidget" data-href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/" data-send="false" data-width="450" data-show-faces="false" data-action="like" data-layout="box_count" data-font="arial" rel="nofollow"><span class="vhidden">Share on Facebook</span></a>
						</li><br />
						<!-- Linked In link -->
						<li class="linkedIN shareWidget">
						    <a href="#" class="socialite linkedin linkedin-share" data-url="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/" data-counter="top" rel="nofollow" target="_blank"><span class="vhidden">Share on Linkedin</span></a>
						</li>
						<li class="plusOne shareWidget">
						    <a href="#" class="socialite googleplus googleplus-one"  data-size="tall" data-href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/" rel="nofollow" target="_blank"><span class="vhidden">Share on Google</span></a>
						</li>
						<li class="hackerNews shareWidget">
						    <a href="http://news.ycombinator.com/submit" class="socialite hn-share-button hackernews-share"><span class="vhidden">Submit to Hacker News</span></a>
						</li>
					</ul>
					</div>
					
					<div class="story_sidebar_insert">
						 
					</div> 

				</div>
						
			<p><a href="http://www.sec.gov/Archives/edgar/data/1110803/000111080312000041/ilmn-201110k.htm" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.sec.gov']);" rel="external" title="" class="ext-link" target="_blank">Illumina</a> is like the Apple of the genomics business. Tools made by the San Diego company (NASDAQ: <a href="http://finance.yahoo.com/q?s=ILMN" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://finance.yahoo.com']);" rel="external" title="" class="ext-link" target="_blank">ILMN</a>) are revered by genomics researchers around the world just like millions of consumers love their iPhones and iPads. And Illumina holds its dominant position at an enviable moment in history, as we&#8217;re heading into a scientific golden age when human genomes will be sequenced for $1,000 or less.</p>
<p>Yet here we are, after more than a month of silly posturing, and Switzerland-based pharma giant Roche is still behaving as if Illumina shareholders are fools who will act on short-term greedy impulse and sell their company for less than it&#8217;s worth. The stance is insulting and wrong. If this low-ball takeover deal somehow gets done, it would be bad for Illumina shareholders, bad for the genetic tools industry, bad for science, bad for the San Diego innovation community, and bad for the personalized medicine movement.</p>
<p>This whole Roche/Illumina story burst out into public view on Jan. 25, when Roche said it was making an unsolicited bid to buy Illumina for $44.50 a share, or about $5.7 billion. The <a href="http://www.roche.com/media/media_releases/med-cor-2012-01-25.htm" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.roche.com']);" rel="external" title="" class="ext-link" target="_blank">press release</a> announcing the move was typically upbeat. Instead of saying the bid was 18 percent higher than the prior day&#8217;s closing stock price, Roche spun the story to make the bid look more generous, saying it was 61 percent higher than Illumina&#8217;s share price of Dec. 21, the day before rumors leaked that Illumina might be sold. Roche, the world&#8217;s largest maker of cancer drugs and a leader in the diagnostics industry, argued that this deal would essentially hasten the arrival of the era of personalized medicine.  Roche&#8217;s Daniel O&#8217;Day, the operating chief of the company&#8217;s diagnostics division, said in a statement that Illumina would enable the company to offer a &#8220;total solution&#8221; which would help researchers discover new biomarkers and pick patients likely to respond to specific drugs.</p>
<p>Roche CEO Severin Schwan described the offer as providing &#8220;<a href="http://www.bio-itworld.com/els/2012/02/06/roche-calls-illumina-offer-full-fair.html" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.bio-itworld.com']);" rel="external" title="" class="ext-link" target="_blank">full and fair value</a>&#8221; to Illumina shareholders.</p>
<p>But this offer is nothing close to &#8220;full and fair.&#8221; It would be more fair to say this action is like kicking a man in the ribs when he&#8217;s on the ground. Illumina stock traded as high as $79.40 a share in the last year. The only reason Roche was in position to make such a low-ball offer of $44.50 is because <a href="http://www.xconomy.com/san-diego/2011/10/07/illumina-stock-dives-on-weak-quarterly-sales-report/" >Illumina stock plummeted last fall</a>, after scientific customers stalled purchases in the third quarter because they feared federal research budget cuts. That concern is real, but despite the negative force, Illumina rebounded some in the fourth quarter and now forecasts 4 percent to 11 percent sales growth this year. That&#8217;s a strong sign of resilience, when everyone from Life Technologies to Complete Genomics to PacBio and others are trying their best to knock Illumina off its pedestal. During this remarkable stretch of innovation in genomics, Illumina remains the dominant player with a 60 percent share of the next-generation sequencing market. About 90 percent of the world&#8217;s DNA sequencing output is now done on Illumina machines, the company said in a Feb. 7 regulatory <a href="http://www.sec.gov/Archives/edgar/data/1110803/000119312512043693/d295981dsc14d9.htm" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.sec.gov']);" rel="external" title="" class="ext-link" target="_blank">filing</a>. Forecasting the growth of the market is tricky, but it is expected to grow fast as more scientists get access to genetic analysis machines as they get cheaper.</p>
<p>&#8220;The Board believes that Illumina is singularly positioned in a nascent industry, which has the promise and potential to experience extraordinary growth in the years ahead as genetic information becomes broadly applied beyond molecular biology research and into medical diagnostics,&#8221; the company said in the filing.</p>
<p>Shareholders aren&#8217;t taking the Roche bid very seriously. Roche said that Illumina shareholders had agreed to fork over 102,165 shares at Roche&#8217;s desired $44.50 price by its previous deadline of Feb. 24. Given that Illumina has 122 million shares outstanding, Roche still has a lot of persuading to do. But instead of sweetening its offer, Roche <a href="http://www.roche.com/media/media_releases/med-cor-2012-02-27.htm" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.roche.com']);" rel="external" title="" class="ext-link" target="_blank">extended</a> the deadline to March 23, and started mounting a campaign to win a controlling majority of seats on the Illumina board at this spring&#8217;s annual shareholder meeting. Illumina shareholders have continued to bid up the stock, to $51.35 at Friday&#8217;s close, which could be a signal that many expect a much higher bid to come.</p>
<p>When I looked over the various company statements and SEC filings on this Roche/Illumina battle late Friday, I tried to come up with a list of &#8220;reasons for Illumina to sell&#8221; and &#8220;reasons to remain independent.&#8221; One executive at a genomic computing company&#8212;<a href="http://www.xconomy.com/san-francisco/2011/10/18/nextbio-sees-growth-in-next-market-physicians-seeking-help-interpreting-individual-genomes/" >Saeid Akhtari</a> of Cupertino, CA-based NextBio&#8212;told me he&#8217;s optimistic that a Roche takeover would lead to &#8220;rapid development of new technologies offering more efficiency in data production resulting in more research, data and discoveries.&#8221; But try as I might to see the advantage of a sale to Roche&#8212;even at a price of $60 a share or more&#8212;I just don&#8217;t think it makes sense. Here are five key reasons why I think Illumina shareholders should stand firm, and reject Roche&#8217;s offer.</p>
<p><strong>Reason #1: The price is too low.</strong></p>
<p>JP Morgan analyst Tycho Peterson, in a detailed note to clients on Feb. 9, wrote that Roche&#8217;s offer isn&#8217;t close to good enough. He has a $70 price target on Illumina shares. &#8220;With technology leadership and the potential for open-ended growth, Illumina remains an extremely attractive asset, and we think the stock is likely to command a larger premium,&#8221; Peterson wrote.</p>
<p>Peterson&#8217;s report has some compelling logic that shows why Illumina would be nuts to sell today. While the concerns about budget constraints at the National Institutes of Health are real&#8212;and most scientists who buy Illumina machines depend on NIH funding&#8212;that customer base is just where the story begins for Illumina. Future markets are potentially much bigger. If newborns start getting their genomes sequenced in large numbers, and Illumina can capture 10 percent of the addressable market over time, that segment alone is worth $3.5 billion, Peterson wrote. If cancer patients routinely get their full genomes sequenced instead of getting a hodgepodge of specific diagnostic tests, Illumina could pull in $2.5 billion by capturing one-tenth of that available market. If pharmaceutical companies routinely start sequencing genomes of patients in clinical trials to enable more personalized medicine, and Illumina gets that same 10 percent market share, that will be worth $240 million. Taken together, those three markets could add $6 billion in revenues&#8212;about six-times more than the amount of revenue Illumina generated in the past year, Peterson said. Illumina has resisted so far, calling the offer &#8220;grossly inadequate.&#8221;</p>
<p>Bottom line, this is a miserly offer for a company with market leading technology, in a market that is only just now starting to head into adolescence.</p>
<p><strong>Reason #2. Illumina&#8217;s operations would likely flounder at Roche.</strong></p>
<p>Sometimes it makes sense for a company to get acquired when the existing management team has burned out, or gotten to a transition point where it needs the expertise or greater resources of an acquirer. That&#8217;s not the case with Illumina. CEO <a href="http://www.xconomy.com/san-diego/2010/04/06/illumina-ceo-jay-flatley-on-how-to-keep-an-edge-in-the-fast-paced-world-of-gene-sequencing/" >Jay Flatley</a> has been on the job since 1999, and guided the company through its rise to pre-eminence. He&#8217;s 59 years old, and he&#8217;s surrounded by plenty of talent on the board and executive team. Flatley personally holds a 1.7 percent ownership stake in Illumina stock, so you could say he&#8217;s motivated to make Illumina succeed.</p>
<p>Compare that with Roche&#8217;s record in the genetic analysis tools business. Back in 2007, Roche <a href="http://www.roche.com/med-cor-2007-03-29" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.roche.com']);" rel="external" title="" class="ext-link" target="_blank">bought</a> 454 Life Sciences. Founder Jonathan Rothberg promptly <a href="http://www.forbes.com/forbes/2011/0117/features-jonathan-rothberg-medicine-tech-gene-machine.html" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.forbes.com']);" rel="external" title="" class="ext-link" target="_blank">left</a> and founded a groundbreaking rival in the DNA sequencing business&#8212;Ion Torrent Systems. And what became of 454 once it was part of Roche? Not much. How about <a href="http://www.roche.com/med-cor-2007-06-19" onclick="javascript:_gaq.push(['_trackEvent','outbound-article','http://www.roche.com']);" rel="external" title="" class="ext-link" target="_blank">NimbleGen Systems</a>, the maker of microarray technologies? Have you much about that system since it was absorbed into the belly of Roche five years ago?</p>
<p>Any company that hopes to integrate genomics into the diagnostic and pharmaceutical business is going to have to have extreme determination, focus, technical chops, stamina, and money. Roche clearly has some very smart people in its organization&#8212;it bought South San Francisco-based Genentech in 2009. But coordinating so many people from different disciplines, at any company the size of Roche with 80,000 employees worldwide, is asking for trouble. Creating the future of genomic diagnostics will take the focus, brainpower, and determination of a leaner organization concentrated in one place, like Illumina.</p>
<p><strong>Reason #3: Illumina&#8217;s innovation edge would be dulled.</strong></p>
<p>Illumina has been remarkably driven to hold onto its market leadership, and has continued to make its instruments better, faster, and cheaper to fend off rivals like Life Tech, PacBio, and Complete Genomics. Oxford Nanopore was the latest upstart <a href="http://www.xconomy.com/national/2012/02/21/oh-and-one-more-thing-a-wowser-moment-in-dna-sequencing/" >to wow industry analysts a couple weeks ago</a> at a conference, but sure enough, Illumina had the foresight <a href="http://www.xconomy.com/san-diego/2010/02/01/illumina-bets-again-on-oxford-nanopore-joins-28m-investment-in-cheaper-gene-sequencing/" >to invest in that company</a> three years ago. People at all those small organizations know their company&#8217;s future depends on their efforts, and they have a chance to do something historic. But for people who work at Roche, they know their company will be fine whether some Illumina division thrives or not. There&#8217;s no way the average salaried worker can compete with the fire in the belly you&#8217;ll find at these startups. <a href="http://www.xconomy.com/national/2011/09/15/ion-torrents-fast-and-cheap-dna-sequencer-catches-on-even-as-biologists-tighten-belts/" >Rothberg told me last fall</a> that he couldn&#8217;t possibly give out some basic information like his R&amp;D budget, because that would be giving away too much to his competitors. His team is working so feverishly that &#8220;this is like 1948 and we&#8217;re the Israelis,&#8221; he said. I can&#8217;t imagine people at a Roche/Illumina division working with that kind of burning intensity to keep their innovative edge.</p>
<p><strong>Reason #4. Anti-trust concerns start becoming real if Roche gets Illumina.</strong></p>
<p>You have to wonder if anti-trust regulators might look askance at a single organization building a dominant position in cancer drugs, diagnostics, and now genomic analysis instruments. My guess is that this would probably pass muster with regulators, because no company has a true monopoly on any of these industries. But it&#8217;s conceivable that a company the size of Roche could use unfair &#8220;bundling&#8221; techniques that would hurt DNA sequencing competitors and consumers.</p>
<p><strong>Reason #5. The innovation community would be harmed.</strong></p>
<p>This is the one argument you rarely hear, but it needs to be raised. Illumina is an anchor of the San Diego biotech hub, and one of the great stories of American technological innovation of the past decade. It employs 2,200 people in positions that provide work with meaning, good wages, good benefits, and relative stability in a volatile industry. Roche said some things in January about how it wants to establish an &#8220;Applied Science&#8221; division in San Diego, but it wouldn&#8217;t be the same as Illumina. If this deal goes through, it would weaken the San Diego biotech community, and American competitiveness.</p>
<p>For these reasons, I&#8217;m hopeful that Illumina and its shareholders will weather this storm. I&#8217;m willing to bet that five years from now, when sequencing is part of mainstream medicine, people will chuckle over memories that Roche once tried to pull a fast one, and buy Illumina on the cheap.</p>
						
			
			<div class="shareLinks horiz">
				<h3>
					Share or Leave a Comment
				</h3>
					
					<a class="reprints horiz" href="/reprints" id="lowerReprints">
            Reprints
          </a>
          <a href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/email/"
             title="E-mail" rel="nofollow" target="_blank" class="reprints horiz" id="lowerEmail">
            E-mail
          </a>
          <a class="reprints horiz" href="http://www.shareaholic.com/api/share/?v=1&apitype=1&apikey=2fc518bd8c0bb3cf45bdade11877971c1&service=304&title=&link=http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/&shortener=none" rel="nofollow" target="_blank" title="Share on Google Plus" id="lowerGoogle">
						+1
					</a>
					
					<!-- Twitter link -->
					<a class="reprints horiz" href="http://www.shareaholic.com/api/share/?v=1&apitype=1&apikey=2fc518bd8c0bb3cf45bdade11877971c1&service=7&title=&link=http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/&shortener=none" rel="nofollow" target="_blank" title="Share on Twitter" id="lowerTwitter">
						Twitter
					</a>            
					
					
					<!-- Linked In link -->
					<a class="reprints horiz" href="http://www.shareaholic.com/api/share/?v=1&apitype=1&apikey=2fc518bd8c0bb3cf45bdade11877971c1&service=88&title=&link=http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/&shortener=none" rel="nofollow" target="_blank" title="Share on LinkedIn" id="lowerLinkedin">
						LinkedIn
					</a>

					<a class="reprints horiz" href="http://www.shareaholic.com/api/share/?v=1&apitype=1&apikey=2fc518bd8c0bb3cf45bdade11877971c1&service=5&title=&link=http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/&shortener=none" rel="nofollow" target="_blank" title="Share on Facebook" id="lowerFacebook">
						Facebook
					</a>
				
					<a class="reprints horiz" href="http://www.shareaholic.com/api/share/?v=1&apitype=1&apikey=2fc518bd8c0bb3cf45bdade11877971c1&service=202&title=&link=http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/&shortener=none" rel="nofollow" target="_blank" title="Share on Hacker News" id="lowerHackerNews">
						Hacker News
					</a>

          <a href="http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/#disqus_thread" class="reprints horiz commentnow">Comment</a>			
			</div>

			<div class="postArticle clearFix">
				<div class="adSlot">
					<!--/* Adzerk ad */-->
					<div id="az_single_1">
						<script type="text/javascript">
							ados_loadDiv("az_single_1");
						</script>
					</div>
				</div>
	  							<div class="relatedMeta">
			  		<h3>Related Posts</h3>
					<ul><li><a href="http://www.xconomy.com/san-diego/2012/04/18/illumina-stays-independent-roche-walking-away/" rel="bookmark" title="April 18, 2012">Illumina Stays Independent, Roche Walking Away</a></li>

<li><a href="http://www.xconomy.com/san-diego/2012/01/25/roche-makes-5-7b-hostile-takeover-bid-for-illumina/" rel="bookmark" title="January 25, 2012">Roche Makes $5.7B Hostile Takeover Bid for Illumina</a></li>

<li><a href="http://www.xconomy.com/san-diego/2012/03/29/roche-raises-illumina-takeover-bid-to-51share/" rel="bookmark" title="March 29, 2012">Roche Raises Illumina Takeover Bid to $51/Share</a></li>

<li><a href="http://www.xconomy.com/national/2013/04/29/six-reasons-why-illumina-has-nothing-to-fear-from-thermolife-merger/" rel="bookmark" title="April 29, 2013">Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life</a></li>

<li><a href="http://www.xconomy.com/san-diego/2012/09/19/illumina-steps-up-diagnostics-game-acquires-uks-bluegnome/" rel="bookmark" title="September 19, 2012">Illumina Steps Up Diagnostics Game, Acquires UK’s BlueGnome</a></li>
</ul><!-- Similar Posts took 318.435 ms -->				</div>
							</div>
		</div>
		<p class="smallText dimText">By posting a comment, you agree to our <a href="/terms-conditions">terms and conditions</a>.</p>		

		
<div id="disqus_thread">
                    <div id="dsq-content">


            <ul id="dsq-comments">
                    <li class="comment even thread-even depth-1" id="dsq-comment-599385">
        <div id="dsq-comment-header-599385" class="dsq-comment-header">
            <cite id="dsq-cite-599385">
http://biotechmarketer.blogspot.com                <span id="dsq-author-user-599385">Shawn Baker</span>
            </cite>
        </div>
        <div id="dsq-comment-body-599385" class="dsq-comment-body">
            <div id="dsq-comment-message-599385" class="dsq-comment-message"><p>I&#8217;m with you all the way up to point #5, but then you lose me. How would keeping Illumina&#8217;s HQ in San Diego and adding to it Roche&#8217;s Applied Science division (which includes 454 and NimbleGen) &#8220;weaken the San Diego biotech community, and American competitiveness.&#8221;? They&#8217;re not talking about creating an &#8216;applied science&#8217; division which would contain part of what Illumina is today, but consolidating that whole division (apart from a site in Germany) here in San Diego, adding to what Illumina already has. That seems like a good thing for the local biotech community.</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment odd alt thread-odd thread-alt depth-1" id="dsq-comment-599598">
        <div id="dsq-comment-header-599598" class="dsq-comment-header">
            <cite id="dsq-cite-599598">
                <span id="dsq-author-user-599598">Enjay</span>
            </cite>
        </div>
        <div id="dsq-comment-body-599598" class="dsq-comment-body">
            <div id="dsq-comment-message-599598" class="dsq-comment-message"><p>Roche is not quite the bad guy you like to paint, it is easy to do the big brother thing and criticize Roche et al. Frankly Illumina are a poorly managed company missing its potential by miles dispite the figures. If Roche don&#8217;t get them someone else will that&#8217;s for sure and that will spell even worse news for the employees.</p>
<p>Roche can easily cite twice as many sucessful acquisitions than you cite supposedly unsucessful ones so your article is bias and misleading.</p>
<p>Rather Roche than Abbott or worse</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment even thread-even depth-1" id="dsq-comment-600201">
        <div id="dsq-comment-header-600201" class="dsq-comment-header">
            <cite id="dsq-cite-600201">
http://molecularfuture.blogspot.com/                <span id="dsq-author-user-600201">Tim Gallagher</span>
            </cite>
        </div>
        <div id="dsq-comment-body-600201" class="dsq-comment-body">
            <div id="dsq-comment-message-600201" class="dsq-comment-message"><p>Good article, Luke.</p>
<p>How about this for reason #6: because the touted &#8220;total solution&#8221; provided by a Roche + Illumina combination is a fairy tale.</p>
<p>Illumina sells equipment.<br />
Roche sells drugs and diagnostics. What tiny bit of equipment that Roche sells (454) hasn&#8217;t done well.</p>
<p>I don&#8217;t see how selling Illumina equipment makes Roche&#8217;s drug or diagnostics businesses any better. </p>
<p>What &#8220;total solution&#8221; becomes enabled by the combo that isn&#8217;t possible by Roche just buying a roomful of Illumina (or someone else&#8217;s) sequencers?</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment odd alt thread-odd thread-alt depth-1" id="dsq-comment-607677">
        <div id="dsq-comment-header-607677" class="dsq-comment-header">
            <cite id="dsq-cite-607677">
                <span id="dsq-author-user-607677">Roger Bumgarner</span>
            </cite>
        </div>
        <div id="dsq-comment-body-607677" class="dsq-comment-body">
            <div id="dsq-comment-message-607677" class="dsq-comment-message"><p>Luke,</p>
<p>I&#8217;m not sure it&#8217;s so simple.  The thing that&#8217;s hard to quantify in this area is the risk.  In particular the risk of being replaced with the next technology.  While Illumina has invested in NanoPore that doesn&#8217;t mean they won&#8217;t be completely out competed by say IBM or some unknown company in the next 2-3 years.  The technology is moving VERY fast.  There&#8217;s significant risk that Illumina can&#8217;t stay on top forever and shareholders need to balance the risk vs. potential reward.  Your analysis is focused more on the reward side of the equation.</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment even thread-even depth-1" id="dsq-comment-608493">
        <div id="dsq-comment-header-608493" class="dsq-comment-header">
            <cite id="dsq-cite-608493">
                <span id="dsq-author-user-608493">梅睿鹏 isaac mehl</span>
            </cite>
        </div>
        <div id="dsq-comment-body-608493" class="dsq-comment-body">
            <div id="dsq-comment-message-608493" class="dsq-comment-message"><p>thanks for the ball-sy and insightful article luke.</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment byuser comment-author-ltimmerman bypostauthor odd alt thread-odd thread-alt depth-1" id="dsq-comment-608948">
        <div id="dsq-comment-header-608948" class="dsq-comment-header">
            <cite id="dsq-cite-608948">
http://www.xconomy.com/author/ltimmerman/                <span id="dsq-author-user-608948">Luke Timmerman</span>
            </cite>
        </div>
        <div id="dsq-comment-body-608948" class="dsq-comment-body">
            <div id="dsq-comment-message-608948" class="dsq-comment-message"><p>Thanks for the comments here.</p>
<p>Shawn&#8211;I hear what you&#8217;re saying about the consolidated Applied Science division, but I&#8217;ve seen companies promise to keep large local R&#038;D centers going for a while, only to pull out later. Not sure I buy the argument that Roche Applied Science would be bigger and better for the SD community than Illumina alone.</p>
<p>Roger&#8211;it&#8217;s a fair question to raise about whether Illumina can retain its edge in sequencing in such a fast-moving market. What we know for sure is that Illumina has held on to market leadership for a number of years now, despite so much competition. I think there&#8217;s a fair chance it can continue to hold on for a good while longer. I don&#8217;t see a need just yet for shareholders to &#8216;take the money and run.&#8217;</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="comment even thread-even depth-1" id="dsq-comment-609034">
        <div id="dsq-comment-header-609034" class="dsq-comment-header">
            <cite id="dsq-cite-609034">
http://biotechmarketer.blogspot.com/                <span id="dsq-author-user-609034">Shawn Baker</span>
            </cite>
        </div>
        <div id="dsq-comment-body-609034" class="dsq-comment-body">
            <div id="dsq-comment-message-609034" class="dsq-comment-message"><p>Luke, that worry about Roche was nagging me at the back of my brain. Consolidating and then pulling out of San Diego (a few years down the road) would be devastating for San Diego. And Roche leaving SD is much more likely than Illumina leaving SD. Hmm&#8230; I still think Roche moving their HQ here would be positive, but perhaps more risky.</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="post pingback">
        <p>Pingback: <a href="http://www.biopharmstocks.com/2012/04/03/illumina-compares-itself-to-apple-in-rejecting-roche-bid/" onclick="javascript:_gaq.push(['_trackEvent','outbound-commentauthor','http://www.biopharmstocks.com']);" rel="external nofollow" class="url ext-link" title="" target="_blank">$LLY News: Illumina Compares Itself to Apple in Rejecting Roche Bid</a></p>
    </li>
    </li><!-- #comment-## -->
    <li class="comment odd alt thread-odd thread-alt depth-1" id="dsq-comment-666143">
        <div id="dsq-comment-header-666143" class="dsq-comment-header">
            <cite id="dsq-cite-666143">
                <span id="dsq-author-user-666143">Saumitra Rahatekar</span>
            </cite>
        </div>
        <div id="dsq-comment-body-666143" class="dsq-comment-body">
            <div id="dsq-comment-message-666143" class="dsq-comment-message"><p>Exemplary piece of journalism Luke ! All of your arguments came true in the end. More ever sequencing is not only meant for Biotech and Pharma. There are various areas in Agriculture which can use Illumina&#8217;s expertise, Forensic science, Animal health (?) and who knows what !</p>
</div>
        </div>

    </li><!-- #comment-## -->
    <li class="post pingback">
        <p>Pingback: <a href="http://www.xconomy.com/national/2012/06/11/ready-or-not-genomics-is-coming-to-a-hospital-near-you/" rel="external nofollow" class="url ext-link" title="" target="_blank">Ready or Not, Genomics is Coming to a Hospital Near You | Xconomy</a></p>
    </li>
    </li><!-- #comment-## -->
    <li class="post pingback">
        <p>Pingback: <a href="http://www.xconomy.com/national/2014/02/03/the-1k-genome-so-what-illumina-is-on-a-quest-for-world-domination/" rel="external nofollow" class="url ext-link" title="" target="_blank">The $1K Genome? So What? Illumina Is On a Quest for World Domination | Xconomy</a></p>
    </li>
    </li><!-- #comment-## -->
            </ul>


        </div>

    </div>

<script type="text/javascript">
/* <![CDATA[ */
    var disqus_url = 'http://www.xconomy.com/national/2012/03/05/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid/';
    var disqus_identifier = '181399 http://www.xconomy.com/?p=181399';
    var disqus_container_id = 'disqus_thread';
    var disqus_domain = 'disqus.com';
    var disqus_shortname = 'xconomy';
    var disqus_title = "Five Reasons Illumina Should Fight Roche&#8217;s Insulting Low-Ball Bid";
    var disqus_config = function () {
        var config = this; // Access to the config object
        config.language = '';

        /* Add the ability to add javascript callbacks */
        
        /*
           All currently supported events:
            * preData — fires just before we request for initial data
            * preInit - fires after we get initial data but before we load any dependencies
            * onInit  - fires when all dependencies are resolved but before dtpl template is rendered
            * afterRender - fires when template is rendered but before we show it
            * onReady - everything is done
         */

        config.callbacks.preData.push(function() {
            // clear out the container (its filled for SEO/legacy purposes)
            document.getElementById(disqus_container_id).innerHTML = '';
        });
                    };
/* ]]> */
</script>

<script type="text/javascript">
/* <![CDATA[ */
    var DsqLocal = {
        'trackbacks': [
            {
                'author_name':    "$LLY News: Illumina Compares Itself to Apple in Rejecting Roche Bid",
                'author_url':    "http:\/\/www.biopharmstocks.com\/2012\/04\/03\/illumina-compares-itself-to-apple-in-rejecting-roche-bid\/",
                'date':            "04\/03\/2012 05:06 PM",
                'excerpt':        "[...] of the genomics business,” the co. announced at the top of a letter to investors, quoting from a recent &hellip;",
                'type':            "pingback"            }
,            {
                'author_name':    "Ready or Not, Genomics is Coming to a Hospital Near You | Xconomy",
                'author_url':    "http:\/\/www.xconomy.com\/national\/2012\/06\/11\/ready-or-not-genomics-is-coming-to-a-hospital-near-you\/",
                'date':            "12\/29\/2012 09:55 PM",
                'excerpt':        "[...] one complete genome that carries the instructions for making cells. A decade later, companies like Illumina (NASDAQ: ILMN) and Life &hellip;",
                'type':            "pingback"            }
,            {
                'author_name':    "The $1K Genome? So What? Illumina Is On a Quest for World Domination | Xconomy",
                'author_url':    "http:\/\/www.xconomy.com\/national\/2014\/02\/03\/the-1k-genome-so-what-illumina-is-on-a-quest-for-world-domination\/",
                'date':            "02\/03\/2014 03:10 AM",
                'excerpt':        "[...] 37 percent in January alone, to close at $152. Not bad for a company that was the subject of &hellip;",
                'type':            "pingback"            }
        ],
        'trackback_url': "http:\/\/www.xconomy.com\/national\/2012\/03\/05\/five-reasons-illumina-should-fight-roches-insulting-low-ball-bid\/trackback\/"    };
/* ]]> */
</script>

<script type="text/javascript">
/* <![CDATA[ */
(function() {
    var dsq = document.createElement('script'); dsq.type = 'text/javascript';
    dsq.async = true;
    dsq.src = '//' + disqus_shortname + '.' + 'disqus.com' + '/' + 'embed' + '.js' + '?pname=wordpress&pver=2.76';
    (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
})();
/* ]]> */
</script>
	</div>
			        </div> <!-- stories / .xconomy wrapper -->
		    </div>

			<div class="yui3-u rightCol">		<!-- BEGIN SIDEBAR -->
		<div class="sidebar breatheMe">
						
  	  	
				<!-- removed code for VC65 page -->
		<div class="advertisement partners">
			<h4 class="ptm mvn">Underwriters and Partners</h4>
			<ul class="ad_list mhm mtn pbm clearFix">
				<!--/* Adzerk advertizers, shortened to z for calls */-->
									<li id=z0 class="side_ad"></li>
									<li id=z1 class="side_ad"></li>
									<li id=z2 class="side_ad"></li>
									<li id=z3 class="side_ad"></li>
									<li id=z4 class="side_ad"></li>
									<li id=z5 class="side_ad"></li>
									<li id=z6 class="side_ad"></li>
									<li id=z7 class="side_ad"></li>
									<li id=z8 class="side_ad"></li>
									<li id=z9 class="side_ad"></li>
									<li id=z10 class="side_ad"></li>
									<li id=z11 class="side_ad"></li>
									<li id=z12 class="side_ad"></li>
									<li id=z13 class="side_ad"></li>
									<li id=z14 class="side_ad"></li>
									<li id=z15 class="side_ad"></li>
									<li id=z16 class="side_ad"></li>
									<li id=z17 class="side_ad"></li>
							</ul>
		</div>
	          	    		
		
		<div class="social">
			<h3>
				Connect with Xconomy
			</h3>
			<ul class="clearFix">
				<li class="facebook">
					<a href="http://www.facebook.com/xconomyinc" target="_blank" id="facebookEvent" title="Connect with Xconomy on Facebook"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/fb.png" alt="Xconomy on Facebook"/></a>
				</li>
				<li class="twitter">
					<a href="http://www.twitter.com/xconomy" target="_blank" id="twitterEvent" title="Follow Xconomy on Twitter"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/tw.png" alt="Xconomy on Twitter" /></a>
				</li>
				<li class="linkedin">
					<a href="http://www.linkedin.com/groups?gid=3557401&mostPopular=&trk=tyah" target="_blank" id="linkedinEvent" title="Join Xconomy on LinkedIn"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/li.png" alt="Xconomy on Linkedin" /></a>
				</li>
				<li class="plus">
				  <a href="https://plus.google.com/u/0/112993273861500254544" target="_blank" id="googleEvent" rel="publisher" title="Find us on Google+"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/gp.png" alt="Xconomy on Google PLus" /></a>
				</li>
				<li class="rss">
					<a href="http://www.xconomy.com/rss-feeds/ " id="rssIcon" title="Subscribe to Xconomy RSS Feeds"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/fi.png" alt="Xconomy Feeds"/></a>
				</li>
        <!-- Icons thanks to Paul Robert Lloyd, http://paulrobertlloyd.com/2009/06/social_media_icons/ -->
			</ul>
		</div>

			<div class="large_ad">
			<div class="advertisement">
				<!--/* Adzerk ad */-->
				<div id="az_sidebar_1">
					<script type="text/javascript">
						ados_loadDiv("az_sidebar_1");
					</script>
				</div>
			</div>
			</div>
						<div class="popular_stories">
			<h3>Xconomy&rsquo;s Most Popular</h3>
			<ol class="sidebarList">
				<li><a href="http://www.xconomy.com/national/2014/06/25/dont-want-google-in-your-house-some-home-tech-startups-to-watch/">Don’t Want Google in Your House? Some Home-Tech Startups to Watch</a></li><li><a href="http://www.xconomy.com/boston/2014/06/02/blackboard-ceo-jay-bhatt-on-the-global-future-of-edtech/">Blackboard CEO Jay Bhatt on the Global Future of Edtech</a></li><li><a href="http://www.xconomy.com/san-diego/2014/06/09/lou-tartaglia-leaves-third-rock-to-run-high-drama-rnai-startup/">Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup</a></li><li><a href="http://www.xconomy.com/san-diego/2014/06/18/we-have-to-find-our-way-eric-topol-of-scripps-on-connected-health/">"We Have to Find Our Way": Eric Topol of Scripps on Connected Health</a></li><li><a href="http://www.xconomy.com/boston/2014/06/12/moderna-changing-its-identity-plots-army-of-mrna-spinouts/">Moderna, Changing Its Identity, Plots Army of mRNA Spinouts  </a></li>			</ol>
			</div>
			
			
			<div class="leads">
				<h3>
					Xconomy on Demand
				</h3>
				<h2>
					<a href="/rss-feeds">
						Did you miss something? Don't despair…
					</a>
				</h2>
				<p>
					Xconomy offers a number of ways to <strong>subscribe for free!</strong>
				</p>
					<a href="/rss-feeds" id="moduleSubscribe" class="moreCTA">
						Subscribe Now
					</a>
			</div>

			
				<div class="large_ad">
					<!--/* Adzerk ad */-->
					<div id="az_sidebar_2">
						<script type="text/javascript">
							ados_loadDiv("az_sidebar_2");
						</script>
					</div>
				</div>



			<div class="bottm_ad_list">

			<div class="bottom_side_ad">
				<!-- IDG badge -->
				<img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/IDG_badge.jpg" alt="IDG Tech Network"/>
			</div>

			<div class="bottom_side_ad">
				<!-- MOZY badge -->
				<a href="http://www.mozy.com/pro">
					<img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/Mozy_badge.jpg" alt="Protected by Mozy"/>
				</a>
				</div>

			<div class="bottom_side_ad">
				<!-- Eventbrite badge -->
				<a href="http://www.eventbrite.com/">
					<img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/Eventbrite_badge.gif" alt="Eventbrite - events made easy"/>
				</a>
			</div>
		</div>
		</div>
		<!-- END SIDEBAR -->
</div>
		</div>
	</div> <!-- page -->
<!-- BEGIN FOOTER -->
	<div class="footer centerAlign mtm">
	<ul class="footer_nav">
		<li><a href="http://www.xconomy.com/">Home</a></li>
		<li><a href="http://www.xconomy.com/privacy-dmca">Privacy/DMCA</a></li>
		<li class="page_item page-item-2"><a href="http://www.xconomy.com/about/">About</a></li>
<li class="page_item page-item-19"><a href="http://www.xconomy.com/contact-us/">Contact Us</a></li>
<li class="page_item page-item-5"><a href="http://www.xconomy.com/archives/">Archives</a></li>
<li class="page_item page-item-9"><a href="http://www.xconomy.com/advertise/">Advertise</a></li>
		<li><a href="http://www.xconomy.com/rss-feeds">Subscribe for Free</a></li>
		<li></li>
	</ul>
	<p class="grey">
	Business, life sciences, and technology news &mdash; covering <a href="/boston">Boston</a>, <a href="/seattle">Seattle</a>, <a href="/san-diego">San Diego</a>, <a href="/detroit">Detroit</a>, <a href="/san-francisco">San Francisco</a>, <a href="/new-york">New York</a>, <a href="/boulder-denver">Boulder/Denver</a>, <a href="/texas">Texas</a>, <a href="/wisconsin">Wisconsin</a> and beyond.
	</p>
		<p class="grey">&copy; 2007-2014, Xconomy, Inc.
		Xconomy is a registered service mark of Xconomy, Inc.
		All rights reserved.
	</p>
	<p class="grey">
	  Website development support from <a href="http://www.linkedin.com/in/andrewkoyfman" class="external" target="_blank" title="Web Development and Architecture">Andrew Koyfman</a> with design support from <a href="http://www.trueitalic.com" class="external" target="_blank" title="Web and User Experience Design">Rob Hunter</a>.
  </p>
	</div>
</div>

<!--[if lt IE 7 ]>
  <script defer src="//ajax.googleapis.com/ajax/libs/chrome-frame/1.0.3/CFInstall.min.js"></script>
  <script defer>window.attachEvent('onload',function(){CFInstall.check({mode:'overlay'})})</script>
<![endif]-->

<!--[if IE]>
<script type="text/javascript">jQuery(document).ready(function($){

    $("ul.primary li").hover(function(){

        $(this).addClass("hover");
        $('ul:first',this).css('display', 'block');

    }, function(){

        $(this).removeClass("hover");
        $('ul:first',this).css('display', 'none');

    });
});
</script>
<![endif]-->

  <script type="text/javascript" src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/js/xconomy-ck.js"></script>

  <!-- Quantcast Tag -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_deleteCustomVar', 4]);
  _gaq.push(['_setCustomVar',4,'Channel','life-sciences, ',3]);
  _gaq.push(['_deleteCustomVar', 1]);
  _gaq.push(['_setCustomVar',1,'Template','Web',3]);
  var _qevents = _qevents || [];

  (function() {
  var elem = document.createElement('script');
  elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js";
  elem.async = true;
  elem.type = "text/javascript";
  var scpt = document.getElementsByTagName('script')[0];
  scpt.parentNode.insertBefore(elem, scpt);
  })();

  _qevents.push({
  qacct:"p-f8V74QixvoMqQ"
  });
  </script>

  <noscript>
  <div style="display:none;">
  <img src="//pixel.quantserve.com/pixel/p-f8V74QixvoMqQ.gif" border="0" height="1" width="1" alt="Quantcast"/>
  </div>
  </noscript>
  <!-- End Quantcast tag -->

  <!-- OwnerIQ Analytics tag -->
  <script type="text/javascript">
  var _oiqq = _oiqq || [];
  _oiqq.push(['oiq_doTag']);

  (function() {
  var oiq = document.createElement('script'); oiq.type = 'text/javascript'; oiq.async = true;
  oiq.src = document.location.protocol + '//px.owneriq.net/stas/s/XCONMY.js';
  var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(oiq, s);
  })();
  </script>
  <!-- End OwnerIQ tag -->

  <!-- BIZIO tag -->
  <script type="text/javascript">
	_bizo_data_partner_id = "2877";
  </script>
  <script type="text/javascript">
	(function(){var b,a,u;a=document.createElement("script");a.type="text/javascript";a.async=true;u=(window.location.protocol==="https:"?"https://sjs.":"http://js.")+"bizographics.com/insight.min.js";a.src=u;b=document.getElementsByTagName("script")[0];return b.parentNode.insertBefore(a,b)})();
  </script>
  <noscript>
	<img height="1" width="1" alt="" style="display:none;" src="//www.bizographics.com/collect/?pid=2877&fmt=gif" />
  </noscript>
  <!--END BIZIO tag -->

      <!-- chartbeat report -->
    <script type="text/javascript">
    var _sf_async_config={uid:29064,domain:"xconomy.com"};
    (function(){
      function loadChartbeat() {
        window._sf_endpt=(new Date()).getTime();
        var e = document.createElement('script');
        e.setAttribute('language', 'javascript');
        e.setAttribute('type', 'text/javascript');
        e.setAttribute('src',
           (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
           "js/chartbeat.js");
        document.body.appendChild(e);
      }
      var oldonload = window.onload;
      window.onload = (typeof window.onload != 'function') ?
         loadChartbeat : function() { oldonload(); loadChartbeat(); };
    })();
    </script>
        <script type="text/javascript">
    // <![CDATA[
        var disqus_shortname = 'xconomy';
        (function () {
            var nodes = document.getElementsByTagName('span');
            for (var i = 0, url; i < nodes.length; i++) {
                if (nodes[i].className.indexOf('dsq-postid') != -1) {
                    nodes[i].parentNode.setAttribute('data-disqus-identifier', nodes[i].getAttribute('rel'));
                    url = nodes[i].parentNode.href.split('#', 1);
                    if (url.length == 1) url = url[0];
                    else url = url[1]
                    nodes[i].parentNode.href = url + '#disqus_thread';
                }
            }
            var s = document.createElement('script'); s.async = true;
            s.type = 'text/javascript';
            s.src = '//' + disqus_shortname + '.disqus.com/count.js';
            (document.getElementsByTagName('HEAD')[0] || document.getElementsByTagName('BODY')[0]).appendChild(s);
        }());
    //]]>
    </script>
<script type='text/javascript'>/* <![CDATA[ */ var portfolioSlideshowOptions = { psFancyBox:true, psHash:0, psThumbSize:'75', psFluid:false, psTouchSwipe:true, psKeyboardNav:true, psBackgroundImages:true, psInfoTxt:'/' };/* ]]> */</script><script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/js/scrollable.min.js?ver=1.2.5'></script>
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/js/fancybox/jquery.fancybox-1.3.4.pack.js?ver=1.3.4a'></script>
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/js/code.photoswipe.jquery-3.0.4.min.js?ver=3.0.4'></script>
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-content/plugins/portfolio-slideshow-pro/js/jquery.cycle.all.min.js?ver=2.99'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var emailL10n = {"ajax_url":"http:\/\/www.xconomy.com\/wordpress\/wp-admin\/admin-ajax.php","max_allowed":"5","text_error":"The Following Error Occurs:","text_name_invalid":"- Your Name is empty\/invalid","text_email_invalid":"- Your Email is empty\/invalid","text_remarks_invalid":"- Your Remarks is invalid","text_friend_names_empty":"- Friend Name(s) is empty","text_friend_name_invalid":"- Friend Name is empty\/invalid: ","text_max_friend_names_allowed":"- Maximum 5 Friend Names allowed","text_friend_emails_empty":"- Friend Email(s) is empty","text_friend_email_invalid":"- Friend Email is invalid: ","text_max_friend_emails_allowed":"- Maximum 5 Friend Emails allowed","text_friends_tally":"- Friend Name(s) count does not tally with Friend Email(s) count","text_image_verify_empty":"- Image Verification is empty"};
/* ]]> */
</script>
<script type='text/javascript' src='http://www.xconomy.com/wordpress/wp-content/plugins/wp-email/email-js.js?ver=2.60'></script>
</body>
</html>